News
10-13-2015, 09:50 PM
The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.
More... (http://www.news-medical.net/news/20151014/SonaCare-Medicals-Sonablate-450-focused-ultrasound-system-receives-FDA-approval-for-ablation-of-prostate-tissue.aspx)
More... (http://www.news-medical.net/news/20151014/SonaCare-Medicals-Sonablate-450-focused-ultrasound-system-receives-FDA-approval-for-ablation-of-prostate-tissue.aspx)